NASDAQ · Medical Devices · USD

Sensus Healthcare, Inc. (SRTS) Stock Analysis

Sensus Healthcare, Inc. (SRTS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

SRTS

$2.86

+$0.11 (+4.00%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SRTS with… →

SRTS Key Statistics

As of Oct 21, 2026

Trading

Open: $2.76
Previous Close: $2.75
Day's Range: 2.76–2.94
52-Week Range: 2.66–5.49
Volume: 5.61K
Beta: 1.19

Valuation

Market Cap: $47.08M
P/E Ratio: unprofitable
P/S ratio: 2.69
EPS (ttm): −0.94

Financials (FY)

Revenue (FY): $27.48M−34.26%
Net Income (FY): −$7.72M−216.13%
Profit margin: −88.45%
Shares Outstanding: 16.46M
1-Year Return: −11.46%

Dividend and dates

Earnings Date: November 5, 2026
Avg Volume: 29.58K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SRTS closed at $2.86, −11.46% over 1 year.

Sensus Healthcare, Inc. (SRTS) has a market capitalization of $47.08M.

In fiscal 2025, SRTS reported revenue of $27.48M.

SRTS Stock Return by Calendar Year

Sensus Healthcare, Inc. (SRTS) 10-year return: what $10,000 became

1 year: $10,000 $8,854; −11.46%
5 years: $10,000 $7,204; −27.96%
10 years: $10,000 $4,504; −54.96%

If you had invested $10,000 in Sensus Healthcare, Inc. (SRTS) 10 years ago, at the close on October 21, 2016, it would have been worth $4,504 at the close on October 21, 2026: −54.96% in total, −7.67% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−68.19%+193.22%−28.14%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	−28.14%
2025	−42.49%
2024	+193.22%
2023	−68.19%
2022	+2.77%
2021	+87.05%
2020	+9.04%
2019	−52.23%
2018	+43.60%
2017	−1.71%
2016 (partial year)	−17.97%

As of October 21, 2026.

SRTS Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$27.48M	−$7.72M	−28.1%
2024	$41.81M	$6.65M	15.9%
2023	$24.41M	$485.00K	2.0%
2022	$44.53M	$24.24M	54.4%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$27.48M	$11.87M	−$10.31M	−$7.72M	−28.1%
2024	$41.81M	$24.43M	$8.09M	$6.65M	15.9%
2023	$24.41M	$14.06M	−$382.00K	$485.00K	2.0%
2022	$44.53M	$29.63M	$14.83M	$24.24M	54.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SRTS Valuation vs Medical Devices Median

Median of 145 stocks

Metric	SRTS	Medical Devices median	vs median
P/S ratio	2.69	2.53	6% above
Profit margin	−88.45%	−14.78%	73.7 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Sensus Healthcare, Inc. (SRTS) is capitalised at $47.08M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 60 employees.

The most recent close on file for SRTS is $2.86, dated October 21, 2026. That is +$0.11 (+4.00%) against the previous close. The 52-week range on file runs from $2.66 to $5.49. The latest close sits 7.52% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $27.48M. Against the prior fiscal year total of $41.81M, that is a change of −34.26%. The same year closed with a net loss of $7.72M. Profit margin runs at −88.45%. That is 73.7 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −0.94.

Across the 4 fiscal years on file, revenue moves from $44.53M in 2022 to $27.48M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 2.69 times revenue. On price-to-sales that is 6.31% above the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −11.46%. Measured over 10 years, that is −7.67% a year compounded. The reported beta is 1.19. Daily returns over the trailing 10 years annualize to a volatility of 73.32%.

Growth & Income

The record shows no dividend for SRTS.

The strongest complete calendar year on file is 2024 at +193.22%; the weakest is 2023 at −68.19%. Of the 9 complete calendar years on file, 5 finished higher. So far in 2026 the total return is −28.14%.

Peer Comparison

Sensus Healthcare, Inc. (SRTS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Sensus Healthcare, Inc.	SRTS	$47.08M	—
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. Sensus Healthcare, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Sensus Healthcare, Inc.

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Visit website →